Literature DB >> 10782397

Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection.

S Stojanov1, J Liese, B H Belohradsky.   

Abstract

We prospectively followed 725 children under 2 years of age with laboratory-diagnosed Bordetella pertussis infection to investigate the hospitalization rate and complications. Diagnosis was made by culture and polymerase chain reaction (PCR) from nasopharyngeal swabs in 11,016 children who presented with > or = 7 days of cough at 63 pediatric practices in Germany. Of these children, 33 (4.5%) were hospitalized at a mean age of 4.8 months (range, 17 days to 19.5 months). Complications occurred in 16 (48%) of the 33 patients. Pneumonia developed in two (6%) children and a convulsion was observed in one (3%). Intensive care monitoring was required for 23 (70%) children. Further complications were bradycardia (21%), apnea (12%), conjunctivitis (12%), loss of weight (12%), otitis media (6%), atelectasis (3%) and dehydration (3%). Children aged 6-24 months who had not received any dose of pertussis vaccine had a ten-fold increased risk of hospitalization compared to those who had been partially or fully immunized (p < 0.05). Pertussis immunization should be given at an early point in time and completely in order to prevent severe courses of pertussis and hospitalization in young children.

Entities:  

Mesh:

Year:  2000        PMID: 10782397     DOI: 10.1007/s150100050056

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.

Authors:  A Polyzou; S Pournaras; U Dafni; D Sofianou; E Christeli; S Patrinos; A Tsakris
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii.

Authors:  U Reischl; N Lehn; G N Sanden; M J Loeffelholz
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Assessment of Tdap administration rates from 2009 to 2012 at a large urban nonteaching hospital.

Authors:  Eric Wombwell; Whitney Palecek; Elizabeth Englin; Tinh Nguyen
Journal:  J Community Health       Date:  2014-02

Review 4.  Diagnosis and management of pertussis.

Authors:  Alberto E Tozzi; Lucia Pastore Celentano; Marta Luisa Ciofi degli Atti; Stefania Salmaso
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

5.  Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age.

Authors:  Rodrigo Vergara; Miguel Tregnaghi; José Ussher; Sofía Navarro; Ricardo Rüttimann; Marcela Potin; Joanne Wolter; Lode Schuerman
Journal:  Eur J Pediatr       Date:  2005-03-22       Impact factor: 3.183

6.  Rapid detection of Bordetella pertussis by real-time PCR using SYBR green I and a LightCycler instrument.

Authors:  S K Poddar
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 7.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

8.  Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis.

Authors:  Kate E Templeton; Sitha A Scheltinga; Anneke van der Zee; Bram M W Diederen; Alida M van Kruijssen; Herman Goossens; Ed Kuijper; Eric C J Claas
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

9.  Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.

Authors:  Caroline Roduit; Paola Bozzotti; Nathalie Mielcarek; Paul-Henri Lambert; Giuseppe del Giudice; Camille Locht; Claire-Anne Siegrist
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.

Authors:  Lucy A McNamara; Tami Skoff; Amanda Faulkner; Lisa Miller; Kathy Kudish; Cynthia Kenyon; Marisa Bargsten; Shelley Zansky; Amy D Sullivan; Stacey Martin; Elizabeth Briere
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.